Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.57% | $1.41B | €454.71B | 65.28% | 76 Outperform | |
| Roche Holding AG | 2.01% | $798.45M | CHF287.83B | 46.38% | 73 Outperform | |
| HSBC Holdings | 1.91% | $758.60M | £212.73B | 37.91% | 80 Outperform | |
| Novartis AG | 1.80% | $713.30M | CHF238.17B | 30.12% | 80 Outperform | |
| AstraZeneca | 1.76% | $699.40M | $319.11B | 31.68% | 80 Outperform | |
| Nestlé SA | 1.53% | $604.61M | CHF201.28B | 12.90% | 71 Outperform | |
| Shell (UK) | 1.40% | $556.81M | £162.38B | 7.18% | 73 Outperform | |
| Siemens | 1.40% | $555.95M | €195.89B | 10.13% | 74 Outperform | |
| SAP SE | 1.30% | $514.34M | €195.52B | -38.18% | 66 Neutral | |
| Banco Santander | 1.20% | $474.19M | €147.24B | 83.93% | 73 Outperform |